Le Lézard
Classified in: Health
Subject: SVY

Depth of Anesthesia Monitoring Market Worth $170 Million by 2024 - Exclusive Report by MarketsandMarketstm


CHICAGO, June 26, 2019 /PRNewswire/ -- According to the new market research report "Depth of Anesthesia Monitoring Market by Product (Devices, Consumables), Device (Module, Standalone), Mode of Purchase (Group Purchasing Organization, Direct Purchase), End User (Hospitals, Ambulatory Surgery Center, Clinic) - US Forecast to 2024", published by MarketsandMarketstm, the US Depth of Anesthesia Monitoring Market was valued at USD 141 million. This market is projected to reach USD 170 million by 2024, at a CAGR of 3.2% during the forecast period.

MarketsandMarkets Logo

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243124200

The growing patient pool in hospitals and the increasing number of surgeries are the major factors that are driving the growth of this market. However, the high installation and maintenance costs of depth of anesthesia monitoring devices are expected to restrain the growth of this market in the coming years. 

Consumables segment accounted for the largest share of the US Depth of Anesthesia Monitoring Market, by product type, in 2018

Based on product type, the US Depth of Anesthesia Monitoring Market is segmented into devices and consumables. In 2018, the consumable segment accounted for the largest share of the market owing to the need for repeat purchase of consumables and the high adoption of single-use sensors. On the other hand, the average life span of depth of anesthesia monitoring devices is around 10 years, and these devices can be provided at no cost if a long-term contract is signed for the purchase of consumables. 

Browse in-depth TOC on "Depth of Anesthesia Monitoring Market"

25 ? Tables 
9 ? Figures  
51 ? Pages

Modules segment accounted for the largest share of the US Depth of Anesthesia Monitoring Market, by device type, in 2018

On the basis of device type, the US Depth of Anesthesia Monitoring Market is segmented into modules, bundled devices, and standalone devices. The modules segment accounted for the largest share of this market in 2018 majorly due to their widespread use in different clinical settings as they can be integrated into different DOA devices.

Hospitals are the largest end-users of depth of anesthesia monitoring products in the US

Based on end user, the US Depth of Anesthesia Monitoring Market is segmented into hospitals and ambulatory surgical centers & Clinics. The hospitals segment accounted for the largest share of this market in 2018 and is estimated to grow at a higher CAGR during the forecast period majorly due to the growing patient pool in hospitals and the increasing number of surgeries. As the installation and maintenance costs of depth of anesthesia monitoring devices are very high, large hospitals usually can afford to invest in these devices as compared to small clinical settings.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=243124200

The prominent players operating in this market are Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Medtronic Public Limited Company (Ireland), GE Healthcare (US), Mennen Medical Ltd. (Israel), Masimo Corporation (US), and Philips Healthcare (Netherlands).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Patient Monitoring Devices Market by Product (EEG, EMG, MEG, TCD, Peak Flow Meter, Pulse Oximeter, Fetal Monitoring, Temperature Monitoring Devices, MCOT, ECG, Hemodynamic Monitoring System), End User (Home, Hospital) - Global Forecast to 2023

Bed Monitoring System & Baby Monitoring System Market by Type (Baby Monitor (Sensor & Wearable), Pressure Ulcer, Elderly Monitor (Fall Prevention), Sleep Monitor), End User (Home Care, Nursing Home & Assisted Living Facilities) - Global Forecast to 2024

About MarketsandMarketstm 

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model ? GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected] 
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/depth-anesthesia-monitoring-market.asp 
Visit Our Website: https://www.marketsandmarkets.com 
Content Source: https://www.marketsandmarkets.com/PressReleases/depth-anesthesia-monitoring.asp

SOURCE MarketsandMarkets


These press releases may also interest you

at 08:03
The American Red Cross celebrates The Church of Jesus Christ of Latter-day Saints, headquartered in Salt Lake City, for its substantial donation of $7.35 million. The gift will help purchase blood equipment and biomedical emergency vehicles and will...

at 08:00
A Canada-wide Settlement Agreement was recently reached in a class action against Cook (Canada) Inc., Cook Incorporated, and William Cook Europe APS ("Cook") related to certain inferior vena cava filter products ("IVC Filter Products") marketed and...

at 08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug...

at 08:00
Key Proteo, a pioneering proteomics diagnostics company specializing in the enhanced early detection of rare but treatable genetic disorders, today announced that it has submitted a de novo classification request to the U.S. Food and Drug...

at 08:00
Human Immunology Biosciences (HI-Biotm), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced that two abstracts have been accepted for oral presentation at the...

at 08:00
PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today announced positive interim results from the Phase 1 (Part A) clinical trial of Zolmitriptan PassPort® utilizing its...



News published on and distributed by: